These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13069590)

  • 21. Exophthalmos in autoimmune thyroid disease.
    Amino N; Yuasa T; Yabu Y; Miyai K; Kumahara Y
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1232-4. PubMed ID: 6893711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.
    Bunevicius R; Prange AJ
    CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease.
    O'Donnell J; Trokoudes K; Silverberg J; Row V; Volpé R
    J Clin Endocrinol Metab; 1978 May; 46(5):770-7. PubMed ID: 233633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [THE EVOLUTION OF EXOPHTHALMOS AFTER THYROIDECTOMY].
    DA ROSA JC
    Rev Assoc Med Bras; 1963 Apr; 9():137-8. PubMed ID: 14072161
    [No Abstract]   [Full Text] [Related]  

  • 26. Graves' ophthalmopathy.
    Yeatts RP; Clontz DM
    J Ophthalmic Nurs Technol; 1990; 9(1):16-21. PubMed ID: 2313706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ophthalmopathy of Graves' disease.
    Carter JA; Utiger RD
    Annu Rev Med; 1992; 43():487-95. PubMed ID: 1580604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Exophthalmos--what now?].
    Heufelder AE; Schworm HD
    Ther Umsch; 1999 Jul; 56(7):408-14. PubMed ID: 10434781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy for Graves' ophthalmopathy].
    Zheng J; Zhang X; Gong R; Wang J; Tan T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Oct; 21(5):876-9. PubMed ID: 15553880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Goiter Dispersion Formula on Serum Cytokines in Hyperthyroidism Patients with Neurologic Manifestations of Graves' Disease: A Randomized Trial on 80 Cases.
    Tian WH; Wang Y; Yang R; Hu HB
    J Altern Complement Med; 2018 May; 24(5):481-485. PubMed ID: 29406821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should the primary treatment of hyperthyroidism be surgical?
    Linos DA; Karakitsos D; Papademetriou J
    Eur J Surg; 1997 Sep; 163(9):651-7. PubMed ID: 9311471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of hyperthyroidism due to Graves' disease: frequently asked questions and answers (if any).
    Bartalena L; Chiovato L; Vitti P
    J Endocrinol Invest; 2016 Oct; 39(10):1105-14. PubMed ID: 27319009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of the treatment of hyperthyroidism on the course of exophthalmos].
    Vázquez-Chávez C; Nishimura Meguro E; Espinosa Said L; Delgado Falfari A; Sáinz de Viteri M
    Rev Invest Clin; 1992; 44(2):241-7. PubMed ID: 1439313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regression of the carotid intima media thickness by propylthiouracil therapy in Graves' hyperthyroidism.
    Bilir C; Gökosmanoglu F; Caliskan M; Cinemre H; Akdemir R
    Am J Med Sci; 2012 Apr; 343(4):273-6. PubMed ID: 21825964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective screening for coeliac disease in patients with Graves' hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies.
    Ch'ng CL; Biswas M; Benton A; Jones MK; Kingham JG
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):303-6. PubMed ID: 15730411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration inhibition factor (MIF) test.
    Munro RE; Lamki L; Row VV; Volpé R
    J Clin Endocrinol Metab; 1973 Aug; 37(2):286-92. PubMed ID: 4740520
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical progress in the treatment of exophthalmos of Graves' disease, with particular reference to the effect of pituitary surgery.
    McCULLAGH EP; CLAMEN M; GARDNER WJ
    J Clin Endocrinol Metab; 1957 Nov; 17(11):1277-92. PubMed ID: 13475468
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis of exophthalmos using orbital ultrasonography and treatment of malignant exophthalmos with steroid therapy, orbital radiation therapy, and plasmapheresis.
    Yamamoto K; Saito K; Takai T; Yoshida S
    Prog Clin Biol Res; 1983; 116():189-205. PubMed ID: 6134291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease.
    Bunevicius R; Velickiene D; Prange AJ
    Gen Hosp Psychiatry; 2005; 27(2):133-9. PubMed ID: 15763125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.